Plain-English translation of NCT06979180 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing whether Papillex®, a dietary supplement containing vitamins, minerals, and plant extracts, can help reverse abnormal cervical cells caused by HPV infection. The trial will compare the medication to a placebo (a dummy pill with no active ingredients) over six months to see if it actually works and is safe.
Many women develop abnormal cervical cells from HPV infection, and doctors want to find non-surgical treatment options to help reverse these changes before they become more serious. This trial explores whether a targeted supplement approach might support your body's natural ability to heal these cells.
You likely qualify if…
You likely don't qualify if…
You would take either the supplement or a placebo pill daily for 180 days (about six months). During this time, you'll visit the clinic several times for check-ups, including cervical exams (Pap smears), HPV testing, and blood work to monitor your health. You'll also complete some questionnaires about how you're feeling. At the end of six months, the doctors will compare your cervical cells to see if the supplement helped reverse the abnormal changes.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Canada